An anti–TROP-2 antibody–drug conjugate binds TROP-2, is internalized, and releases a camptothecin (topoisomerase I–inhibiting) payload that blocks DNA replication, causing cell-cycle arrest and apoptosis of TROP-2–expressing cells.